Nicholas A. Livingston, PhD
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Psychiatry

PhD, University of Montana



Dr. Livingston received his PhD from the University of Montana and completed his predoctoral internship at VA Boston Healthcare System (rotations: Alcohol and Drug Treatment Program, Substance Abuse Residential Rehabilitation Treatment Program, and Women's Trauma Recovery Program). He subsequently completed the 2-year VA Interprofessional Advanced Fellowship in Addiction Treatment at VA Boston, with an emphasis in substance use disorder (SUD) and PTSD research and treatment. Dr. Livingston is currently a Principal Investigator in the National Center for PTSD, Behavioral Science Division, and Assistant Professor of Psychiatry at Chobanian and Avedisian School of Medicine. His clinical appointment is in the Alcohol and Drug Treatment Program, VA Boston Medical Center, JP. Primary clinical expertise includes evidence-based SUD and PTSD treatment, and patient centered adaptations to evidence-based care.

Primary research interests include substance use and disorder, treatment access and outcomes, and adverse events (e.g., overdose); the longitudinal course of trauma, PTSD, and interrelated psychiatric sequelae; and health disparities. Current funding supports examinations of the impacts of COVID-19 and medication for opioid use disorder (MOUD) policy changes on access to care and patient outcomes (e.g., relapse, mortality; PCORI COVID-2020C2-11081; PI: Livingston), the long-term impacts of combat and other traumas among OEF/OIF/OND veterans (W81XWH-22-S-TBIPH2; PIs: Marx & Bovin), and various studies focused on VA health services and patient outcomes. Current priorities include improving access to MOUD and treatment retention, substance use and relapse tracking using electronic medical record data (via Natural Language Processing and Large Language Models), modeling risk for acute and substance-attributable death among veterans with SUD, and identifying and addressing health disparities.

Dr. Livingston is also a primary or co-mentor on early career development awards (e.g., K, VA CDA-2) and core research training faculty for the Boston University NIMH T32, VA Medical Informatics Fellowship, VA Interprofessional Advanced Fellowship in Addiction Treatment, and other psychology training programs at VA Boston Healthcare System.

Psychologist
VA Boston Healthcare System
National Center for PTSD




Comparing Treatment Use, Retention, and patient outcomes pre-and post-implementation of federal policy changes regulating buprenorphine and methadone treatment for opioid use disorder
08/01/2025 - 10/31/2029 (PI)
Patient-Centered Outcomes Research Institute


Engaging Veterans Seeking Service-Connection Payments in Pain Treatment
08/16/2019 - 08/31/2024 (Subcontract PI)
Yale University NIH NCCIH
5UH3AT009758-06



Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Website       Copy PMIDs To Clipboard

  1. Fonda JR, Loeffel LB, Livingston NA, Knoff AA, Bravman V, Gradus JL, Adams RS. Sex-Specific Associations Between Deployment-Related Traumatic Brain Injury and Nonfatal Drug Overdose Among a National Cohort of Post-9/11 Veterans. J Head Trauma Rehabil. 2025 Aug 21.View Related Profiles. PMID: 40845918; DOI: 10.1097/HTR.0000000000001098;
     
  2. Rosenfeld EA, Malek N, Lockett M, Edward D, Hooper V, Harper KL, Herbitter C, Thompson SM, Ceja A, Saty M, Chang CJ, Collazo EN, Ong L, Stave C, Cudd A, O'Reilly A, Livingston NA. Protocol for a scoping review of PTSD and minority stress interventions for LGBTQIA +?adults. Discov Psychol. 2025; 5(1):54.View Related Profiles. PMID: 40688725; PMCID: PMC12270952; DOI: 10.1007/s44202-025-00355-2;
     
  3. Jones KF, Mandavia AD, Gurewich D, Wyse JJ, Sung ML, Becker WC, Livingston NA. Characteristics of Veterans Receiving Medication for Opioid Use Disorder: An Observational Cohort Study. J Gen Intern Med. 2025 Nov; 40(14):3452-3455.View Related Profiles. PMID: 40588710; PMCID: PMC12586781; DOI: 10.1007/s11606-025-09657-6;
     
  4. Mandavia AD, Fonda JR, Banducci AN, Ameral VE, Sistad Hall RE, Loeffel LB, Roth CE, Simpson TL, Stein MD, Marx BP, Hyde J, Davenport M, Meng F, Livingston NA. Sex and race-ethnicity influences on opioid overdose deaths among veterans diagnosed with opioid use disorder between 2016 and 2021. Drug Alcohol Depend. 2025 Sep 01; 274:112764.View Related Profiles. PMID: 40578052; DOI: 10.1016/j.drugalcdep.2025.112764;
     
  5. Crowe ML, Livingston NA, Keane TM, Marx BP. Measurement invariance of the PTSD checklist for the DSM-5 (PCL-5) in a veteran sample. Psychol Assess. 2025 Sep; 37(9):454-460.View Related Profiles. PMID: 40489149
     
  6. Cook JM, Ellis AE, Simiola V, Martino S, Bellamy C, O'Connell M, Livingston NA. Peer online motivational interviewing and affirmative care for sexual and gender minority men who are survivors of sexual trauma: A randomized clinical trial. J Trauma Stress. 2025 May 30. PMID: 40444426
     
  7. Baier AL, Nillni YI, Mandavia A, Livingston N, Galovski T. Neighborhood context: Understanding the relationship between national indices of neighborhood risk, individual perception, and posttraumatic stress. Soc Sci Med. 2025 Sep; 380:118163.View Related Profiles. PMID: 40403591
     
  8. Livingston NA, Mandavia AD, Banducci AN, Sistad Hall R, Loeffel LB, Davenport M, Mathes-Winnicki B, Ting M, Roth CE, Sarpong A, Newberger N, Hinds Z, Fonda JR, Chen D, Meng F. Identifying opioid relapse during COVID-19 using natural language processing of nationwide Veterans Health Administration electronic medical record data. J Psychopathol Clin Sci. 2025 May; 134(4):448-457.View Related Profiles. PMID: 40111824
     
  9. Banducci AN, Mandavia AD, Bovin MJ, Adams RS, Maloney MA, Roth CE, McClain L, Livingston NA. Opioid overdose, suicide mortality, and premature death among veterans with alcohol or opioid use disorders: The impact of military sexual trauma. Addict Behav. 2025 Aug; 167:108330.View Related Profiles. PMID: 40262404
     
  10. Mandavia AD, Banducci AN, Simpson TL, Marx BP, Hawn SE, Hyde J, Ameral VE, Sistad Hall RE, Roth CE, Sarpong AA, Davenport M, Meng F, Stein MD, Livingston NA. Sex Differences in Suicide, Lethal Means, and Years of Potential Life Lost Among Veterans With Substance Use Disorder. Womens Health Issues. 2025; 35(3):196-204.View Related Profiles. PMID: 40113455
     
Showing 10 of 73 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 73 publications over 12 distinct years, with a maximum of 13 publications in 2024

YearPublications
20142
20153
20163
20171
20181
20192
20207
202110
202212
20238
202413
202511

Note: X.com has changed/limited the ability to embed tweets directly in external sites and we are investigating ways to restore that functionality in BU Profiles. In the meantime we are displaying a link to your x.com profile in the Websites section above.

2024 American Psychological Association, Division 12 (Clinical Psychology): David Shakow Early Career Award
2016 University of Montana: Research & Creative Scholarship Award
2015 American Psychological Association, Division 44 : Malyon-Smith Research Award
2014 Americorps: Americorps Member Service Award
2014-2015 University of Montana: Bertha Morton Research Scholarship
2013-2015 University of Montana: Dr. Morton Greenberger Scholarship
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Substance Use Disorder
Opioid Replacement Therapy
Overdose, Drug
Health Services, Mental
Suicide
Trauma
PTSD
Contact for Mentoring:
Livingston's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Co-Authors
_
Similar People
_
Same Department